Tilray Inc (NASDAQ:TLRY) Shares Purchased by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC boosted its stake in Tilray Inc (NASDAQ:TLRY) by 317.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 166,326 shares of the company’s stock after buying an additional 126,507 shares during the quarter. Wealth Enhancement Advisory Services LLC’s holdings in Tilray were worth $221,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Lido Advisors LLC purchased a new position in Tilray in the 4th quarter valued at about $28,000. Verdence Capital Advisors LLC purchased a new position in Tilray in the 4th quarter valued at about $29,000. Dudley Capital Management LLC purchased a new position in Tilray in the 4th quarter valued at about $29,000. Brooklyn FI LLC purchased a new position in Tilray in the 4th quarter valued at about $36,000. Finally, NewEdge Advisors LLC lifted its stake in Tilray by 92.1% in the 4th quarter. NewEdge Advisors LLC now owns 27,406 shares of the company’s stock valued at $36,000 after buying an additional 13,136 shares in the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

TLRY has been the topic of a number of research reports. Piper Sandler decreased their price target on shares of Tilray from $2.00 to $1.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 9th. Roth Capital reissued a “neutral” rating on shares of Tilray in a research note on Monday, April 14th.

Tilray Trading Up 4.6%

TLRY opened at $0.42 on Tuesday. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.54 and a quick ratio of 1.58. The company’s 50 day simple moving average is $0.45 and its two-hundred day simple moving average is $0.81. Tilray Inc has a 1-year low of $0.37 and a 1-year high of $2.15. The firm has a market capitalization of $425.24 million, a price-to-earnings ratio of -1.41 and a beta of 1.83.

Tilray (NASDAQ:TLRY) last released its earnings results on Tuesday, April 8th. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.06). Tilray had a negative return on equity of 4.40% and a negative net margin of 30.95%. The business had revenue of $185.78 million during the quarter, compared to analysts’ expectations of $213.38 million. Analysts expect that Tilray Inc will post -0.2 EPS for the current fiscal year.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.